section name header

References

Raynaud's Phenomenon and Acrocyanosis - Related Resources

Cochrane reviews

Prazosin may be modestly effective in the treatment of Raynaud's phenomenon secondary to scleroderma Prazosin for Raynaud's Phenomenon in Progressive Systemic Sclerosis.
There is insufficient evidence of the effect of any drugs with vasodilator effects (excluding calcium channel blockers which were not considered in this review) on primary Raynaud's phenomenon Vasodilators for Primary Raynaud's Phenomenon.

Literature

Herrick AL. Management of Raynaud's phenomenon and digital ischemia. Curr Rheumatol Rep 2013;15(1):303. [PubMed]
Goundry B, Bell L, Langtree M et al. Diagnosis and management of Raynaud's phenomenon. BMJ 2012;344:e289.[PubMed]
Baumhäkel M, B�hm M. Recent achievements in the management of Raynaud's phenomenon. Vasc Health Risk Manag 2010;6():207-14.[PubMed]

Primary/Secondary Keywords

Related resources